Dendritic cells are the immune system's master messengers, bridging innate and adaptive defenses.
In short: Named for their tree-like branches, dendritic cells act as the body's sentinels. They constantly sample their environment for pathogens, process the information, and migrate to lymph nodes to instruct T cells and B cells. Without these potent antigen-presenting cells, our adaptive immune response would lack its primary director.
Dendritic cells (DCs) serve as the essential link between the innate and adaptive immune systems. Found in tissues exposed to the external environment—such as the skin, lungs, and gut—these cells function as sentinels that capture antigens from pathogens like bacteria and viruses. Once they encounter a threat, immature DCs mature, upregulate specific receptors, and migrate to lymph nodes. There, they present processed antigen fragments to T cells and B cells, effectively initiating and shaping the body's targeted immune response.
The morphology of these cells is defined by a high surface-to-volume ratio, which facilitates their role as antigen-presenting cells. While they were first described by Paul Langerhans in the late nineteenth century, the term 'dendritic cell' was not coined until 1973 by Ralph M. Steinman and Zanvil A. Cohn. Steinman’s foundational work on their role in immunity earned him the Nobel Prize in Physiology or Medicine in 2011. Despite their importance, DCs are rare and notoriously difficult to isolate, meaning their complex development and subset interrelationships remain only marginally understood.
Beyond their protective role, DCs are implicated in various pathologies. They can be hijacked by viruses like HIV, which use receptors such as DC-SIGN to hitchhike into T cells. Furthermore, altered DC function is linked to autoimmune diseases like lupus and inflammatory bowel disease. Conversely, their presence at tumor sites is often associated with better clinical outcomes, leading to ongoing research into DC-based cancer vaccinations. While follicular dendritic cells (FDCs) share the name, they are distinct, likely originating from mesenchymal tissue rather than the hematopoietic precursors that give rise to conventional and plasmacytoid DCs.
The study of these cells continues to evolve, moving from the use of 'cocktails' of antigens for identification to the modern use of specific markers like BDCA-2 and CD1c. Researchers frequently utilize in vitro models, such as monocyte-derived DCs, to study their behavior, though these laboratory-grown cells do not always perfectly mirror the capabilities of those isolated ex vivo. As our understanding deepens, the potential to harness these cells for therapy remains a frontier in modern immunology.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Dendritic cell
- Also: Frontiers in oncology — A Case Report of follicular dendritic cell sarcoma. · CC BY
To cite this card, link to https://intellectplus.co.uk/app/health-dendritic-cell.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Anatomy and morphology · More in Health · Latest · A–Z · All topics
